Oligonucleotide Therapeutics Society Inc
501C Nonprofit Organization Information
Oligonucleotide Therapeutics Society Inc is a 501(c)(6) board of trade in San Diego, California (EIN 57-1162250). It has been tax-exempt since August 2014, and contributions to it are not tax-deductible. Its Form 990 for tax year 2025 reports total revenue of $1,692,679 and net assets of $2,280,174. TaxExemptWorld has Form 990s on file for 15 tax years (2009–2025). The IRS classifies its activity as Medical Research N.E.C. (NTEE H99). It is one of 13,094 nonprofits in San Diego, CA.
Form 990 · Tax period ending Dec 2025 · Filed May 21, 2026 · From the IRS e-file data
Dollar amounts for every revenue and expense line are in the full 990 report.
Mission (as filed): The Oligonucleotide Therapeutics Society program is delivered through a four-day professional meeting featuring scientific presentations by speakers from industry, academia, and students in the field of oligonucleotide therapeutics. An organizing committee develops the program content and agenda and decides which speakers will present their research. Some speakers are invited directly while others are invited based on submitted abstracts that summarize their research. The organizing committee ensures that the information being presented is current, relevant, and of interest to all constituent groups represented by the society's membership. The program also includes between 250-300 posters which are presented on current research in the industry.Up to fourty Poster Awards are given to the best posters chosen by a selection committee of reviewers made up of members of the Board of Directors and Scientific Advisory Committee. Between 35-50 travel grants are awarded annually to students and
See Schedule O
Prepared by TaxExemptWorld from IRS Form 990 e-file data (object ID 202611419349300746). Not an official IRS form.